Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ALZN — Alzamend Neuro, Inc.

CIK 1214717 BOSTON, MA
Back to ALZN Full portfolio

Position in ALZN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$31,644
-$16,776 QoQ
Shares Held
26,371
-42.3% QoQ
Ownership
0.550%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 12 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALZN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ALZN ranks #489 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ALZN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,644 26,371
2026-03-31 $48,420 45,680
2025-12-31 $50,060 27,506
2025-09-30 $48,974 20,578
2025-03-31 $37,115 39,152
2024-12-31 $38,906 33,540
2024-06-30 $20,644 52,397
2024-03-31 $52,396 52,397
2023-12-31 $46,633 52,397
2023-09-30 $150,734 636,010
2023-06-30 $287,466 563,660
2023-03-31 $239,555 563,660
2022-12-31 $318,467 563,660
2022-09-30 $625,642 525,750
2022-06-30 $35,067 40,587
2022-03-31 $49,922 40,587
2021-12-31 $56,602 29,791
2021-06-30 $389,803 44,600